News & Updates

Body mass index (BMI) has some bearing on the efficacy of different adjuvant chemotherapy schedules in patients with early breast cancer, suggest the results of the GIM2 study, which were presented at the recent SABCS 2023. Additionally, dose-dense (DD) chemotherapy appears to be the better treatment strategy regardless of a patient’s BMI.

A prospective study from Singapore provides evidence of the clinical effectiveness of mRNA-based vaccines against COVID-19 in individuals with cancer.

Researchers from the Chinese University of Hong Kong (CUHK) have demonstrated the potential application of two artificial intelligence (AI) tools, ENDO-AID and AI-Endo, for training endoscopists in early-stage gastrointestinal (GI) cancer management.